Olmesartan Medoxomil/Hydrochlorthiazid Macleods (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Hydrochlorthiazid Macleods, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage hypertension, often in combination with a diuretic, in adult patients. GNH USA supplies Olmesartan Medoxil/Hydrochlorthiazid Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxil/Hydrochlorthiazid Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil/hydrochlorothiazide is indicated for hypertension management, targeting the renin‑angiotensin‑aldosterone system and fluid balance. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure with reduced ejection fraction: assists in fluid removal and blood‑pressure control when used with other guideline‑directed therapies. - Diabetic nephropathy protective effect against progression of renal damage in type 2 diabetes patients by reducing systemic pressure and protein uria.\n

Olmesartan medoxil/hydrochlorothiazide may exhibit several adverse reactions.

Common Side Effects: - Dizziness "); -      "   "  "  "  "  "  "  "  "  ". -  ... ...  .

Serious or Rare ");  "  ");  ". -  " . -  . -  t . -  . -  . -  . -  . -  . -  . -  . -  . -  t . -  . -  t . -  . -  t . -  . -  t ". -  . -  t ". - "); -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  i -  - " -  -  - " -  - " -  -  -  -  - " -  -  -  t -  t

The  t   ewline   ewline ...  ewline  ewline ...